Popularity #2,966Earnings are out
BLSM · NASDAQ · Biotechnology

BlossomHill Therapeutics (BLSM)

Develops oral small-molecule cancer therapies for EGFR, CLK and KRAS targets.

$22.85
vs last close−2.40 (−9.52%)

No ownership filings on record for this listing.